HENNEMAN JOHN B III bought APRE
June 16, 2026 · Form 4 insider transaction
HENNEMAN JOHN B III bought 12,555 shares of Aprea Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,555
Price
$0.00
Total value
N/A
InsiderHENNEMAN JOHN B III
RoleDirector
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 16, 2026
Filing dateJune 17, 2026
Shares owned after12,555
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.